Streptomycin sulfate represents the sulfate salt variant of streptomycin, an antimicrobial agent sourced from the soil-dwelling bacterium Streptomyces griseus. As the pioneer chemotherapeutic medication demonstrated to combat tuberculosis effectively, it marked a monumental milestone in medical history. Because administration relies exclusively on intramuscular injection, its prolonged clinical application remains restricted.

As a potent yet low-toxicity antimicrobial agent sourced from Streptomyces, streptomycin sulfate is predominantly utilized for infections outside the gastrointestinal tract. Functioning as a bactericidal compound, it halts bacterial proliferation by directly binding to cellular ribosomes to block protein synthesis, with its primary clinical indication focused on eradicating extracellular tuberculosis bacilli, such as those localized within cavities.

Parameters
| Melting point | >185°C (dec.) |
| alpha | -79~-88°(20℃/D)(c=1,H2O)(calculated on the dried basis) |
| density | 1.2302 (rough estimate) |
| refractive index | -85 ° (C=1, H2O) |
| storage temp. | 2-8°C |
| solubility | H2O: 0.1 g/mL, clear |
| form | powder |
| color | white to off-white |
| PH | pH (100g/l, 25℃) : 4.5~7.0 |
| Water Solubility | >=0.01 g/100 mL at 18 ºC |
| Merck | 148826 |
| BRN | 3894995 |
| Specific Activity | ≥720IU/g (dry basis) |
| Stability: | Stable. Incompatible with strong oxidizing agents. |
| InChIKey | QTENRWWVYAAPBI-YZTFXSNBSA-N |
| LogP | -1.523 (est) |
| CAS DataBase Reference | 3810-74-0 |
| EPA Substance Registry System | Streptomycin sulfate (3810-74-0) |
Safety Information
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-36/37/38-63-42/43 |
| Safety Statements | 26-36-36/37-45-22-60 |
| WGK Germany | 3 |
| RTECS | WK4990000 |
| F | 3 |
| TSCA | Yes |
| HS Code | 29412000 |
